These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15047655)

  • 1. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden.
    Svensson M; Eriksson JW; Dahlquist G
    Diabetes Care; 2004 Apr; 27(4):955-62. PubMed ID: 15047655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
    Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
    Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
    Svensson M; Sundkvist G; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Henricsson M; Nyström L; Torffvit O; Waernbaum I; Ostman J; Eriksson JW;
    Diabetes Care; 2003 Oct; 26(10):2903-9. PubMed ID: 14514599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.
    Olsen BS; Sjølie AK; Hougaard P; Johannesen J; Marinelli K; Jacobsen BB; Mortensen HB;
    J Diabetes Complications; 2004; 18(3):160-4. PubMed ID: 15145327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.
    Downie E; Craig ME; Hing S; Cusumano J; Chan AK; Donaghue KC
    Diabetes Care; 2011 Nov; 34(11):2368-73. PubMed ID: 22025782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
    Craig ME; Jones TW; Silink M; Ping YJ
    J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
    McCarter RJ; Hempe JM; Gomez R; Chalew SA
    Diabetes Care; 2004 Jun; 27(6):1259-64. PubMed ID: 15161772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental Disorders, Glycemic Control, and Diabetic Complications in Type 1 Diabetes: a Nationwide Cohort Study.
    Liu S; Kuja-Halkola R; Larsson H; Lichtenstein P; Ludvigsson JF; Svensson AM; Gudbjörnsdottir S; Tideman M; Serlachius E; Butwicka A
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4459-e4470. PubMed ID: 34171098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.
    Msanga D; Reis K; Kayange N; Bakalemwa R; Kidenya B; Hau D; Mwanansao C; Mahamba D; Ottaru S; Kwiyolecha E; Peck R
    Ann Glob Health; 2020 Apr; 86(1):43. PubMed ID: 32346524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetes in pre-school children--long-term metabolic control, associated autoimmunity and complications.
    Levy-Shraga Y; Lerner-Geva L; Boyko V; Graph-Barel C; Mazor-Aronovitch K; Modan-Moses D; Pinhas-Hamiel O
    Diabet Med; 2012 Oct; 29(10):1291-6. PubMed ID: 22507070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5 years of childhood onset type 1 diabetes: Systematic review and meta-analysis.
    Mazarello Paes V; Barrett JK; Taylor-Robinson DC; Chesters H; Charalampopoulos D; Dunger DB; Viner RM; Stephenson TJ
    Pediatr Diabetes; 2019 Aug; 20(5):494-509. PubMed ID: 30932298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial.
    Maple-Brown LJ; Ye C; Retnakaran R
    Diabet Med; 2013 Jan; 30(1):95-9. PubMed ID: 22937915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is poor glycaemic control in diabetic patients a risk factor of myopia?
    Jacobsen N; Jensen H; Lund-Andersen H; Goldschmidt E
    Acta Ophthalmol; 2008 Aug; 86(5):510-4. PubMed ID: 18081906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of microangiopathy in children with type 1 diabetes mellitus: a 19-year retrospective study.
    Bouhanick B; Raguin H; Rohmer V; Ebran JM; Simard G; Limal JM
    Diabetes Metab; 2003 Sep; 29(4 Pt 1):395-402. PubMed ID: 14526267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
    J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.